Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes
NCT05899166 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2025-04-24
Summary
The goal of this clinical trial is to test the effects of a ketogenic diet on the progression and control of type 1 diabetes in children with newly diagnosed diabetes. The main questions to answer are:
* Does a ketogenic diet prolong the honeymoon period of type 1 diabetes?
* Does a ketogenic diet improve diabetes control?
* Is a ketogenic diet safe, acceptable and sustainable in children with newly diagnosed diabetes?
* What are the microbiome, inflammatory and metabolic changes linking diet to β-cell function?
Participants will receive a combination of free meals, groceries, micronutrient supplements, and intensive diet and diabetes education for 9 months.
* Diabetes care devices will be connected for cloud-based data collection.
* Bi-weekly data downloads and remote check-ins will assess dietary intake, satisfaction with diet and study procedures, and possible safety concerns.
* During four study visits held at at baseline, 1, 5, and 9 months, an intravenous catheter (IV) will be placed for collection of 5 blood samples before and up to 2 hours after a liquid test meal (protein shake) to assess insulin response. A stool sample will also be collected to assess microbiome changes.
* Children and their caregivers may be invited to participate in a semi-structured interview, and online questionnaires to assess their experience with the diet and diabetes care, general well-being and quality of life.
* Children and their caregivers may be invited to participate in a follow-up visit to evaluate long-term effects after 24 months.
Comparison will be made between a ketogenic vs standard diet.
Conditions
- Diabetes Mellitus, Type 1
Interventions
- OTHER
-
Ketogenic diet, food delivery and education
Meals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
- OTHER
-
Standard diet, food delivery and education
Meals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
Sponsors & Collaborators
-
University of South Florida
collaborator OTHER -
Indiana University
collaborator OTHER - lead OTHER
Principal Investigators
-
Belinda Lennerz · Boston Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 5 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-31
- Primary Completion
- 2028-04-30
- Completion
- 2029-04-30
Countries
- United States
Study Locations
More Related Trials
-
Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy
NCT00552526 ·Status: UNKNOWN ·Phase: PHASE4
-
Ketogenic Diet for Refractory Status Epilepticus
NCT01796574 ·Status: COMPLETED ·Phase: NA
-
Ketonemia Through Menstrual Cycle
NCT05234411 ·Status: UNKNOWN
-
BMI and Its Relationship to Hypoglycemic Seizures in Children With Insulin-requiring Diabetes
NCT00717483 ·Status: COMPLETED
-
Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet
NCT06255873 ·Status: COMPLETED ·Phase: NA
-
Diabetic Ketoacidosis and Its Impact on the Brain
NCT01753934 ·Status: COMPLETED
-
The Effect of Ketogenic Dietary Therapy on Sleep in Adult Epilepsy
NCT04193891 ·Status: TERMINATED
-
Ketogenic Diet for New-Onset Absence Epilepsy
NCT04274179 ·Status: RECRUITING ·Phase: PHASE3
-
Ketogenic Diet for Status Epilepticus in Children Post Cessation of Convulsive Status Epilepticus
NCT05591508 ·Status: UNKNOWN ·Phase: NA
-
RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy
NCT00564915 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial
NCT02176096 ·Status: COMPLETED ·Phase: NA
-
Effects of Exogenous Ketone Ester Supplementation on 3-hydroxybutyrate Concentrations in Human Cerebrospinal Fluid
NCT06318299 ·Status: COMPLETED ·Phase: NA
-
Dietary Therapy in Children With Refractory Epilepsy
NCT01983163 ·Status: COMPLETED ·Phase: PHASE2
-
Ketogenic Diet in Children With Malignant or Recurrent/Refractory Brain Tumor
NCT03328858 ·Status: TERMINATED ·Phase: NA
-
Exogenous Ketone Esters for Refractory Status Epileptics
NCT05674552 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Ketogenic Diet Drink Study
NCT03196271 ·Status: COMPLETED ·Phase: NA
-
Nutritional Formulation for Angelman Syndrome
NCT03644693 ·Status: COMPLETED ·Phase: NA
-
Short-term Ketogenic Diet as Compared With Conventional Long-term Trial in Refractory Infantile Spasms: A Randomized, Controlled Study
NCT00968136 ·Status: COMPLETED
-
Use of the Atkins Diet for Children With Intractable Epilepsy: A Comparison of Daily Carbohydrate Limits
NCT00181090 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Ketogenic Diet on Lipoproteins in Refractory Epilepsy
NCT02644239 ·Status: UNKNOWN ·Phase: NA
-
Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D
NCT03301532 ·Status: COMPLETED ·Phase: PHASE2
-
Modified Atkins Diet in Childhood Epilepsy
NCT00836836 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Management of Drug-resistant Epilepsy in Infants and Children: a Real-life Study of the Use of the Ketogenic Diet in France and the KetoCal® Range in Its Maintenance
NCT06075485 ·Status: RECRUITING
-
Modified Atkins Diet in Children and Adolescents With Drug-resistant Epilepsy
NCT01278966 ·Status: COMPLETED ·Phase: NA
-
The Ketogenic Diet for Pediatric Acute Brain Injury
NCT02174016 ·Status: SUSPENDED ·Phase: NA